Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: A model for prostate cancers in the aged

Cancer Research

Volumn 65, Issue 7, 2005, Pages 2610-2616

  Yamashita, Satoshi ^a   Suzuki, Shugo ^b   Nomoto, Tomoko ^a   Kondo, Yasushi ^c   Wakazono, Kuniko ^a   Tsujino, Yoshimi ^a   Sugimura, Takashi ^a   Shirai, Tomoyuki ^b   Homma, Yukio ^c   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MEMBRANE METALLOENDOPEPTIDASE; UNCLASSIFIED DRUG;

AGED; ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SIZE; CANCER SUSCEPTIBILITY; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME MAP; DNA MICROARRAY; GENE EXPRESSION; GENE LOCUS; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; LINKAGE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLITARY KIDNEY; TESTIS TUMOR; TESTOSTERONE BLOOD LEVEL;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; KIDNEY NEOPLASMS; LEUKEMIA, EXPERIMENTAL; LINKAGE (GENETICS); MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED ACI; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTICULAR NEOPLASMS;

EID: 20144389931     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2932     Document Type: Article

References (44)

1. Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 2001;39:219-26.
2. Deutsch E, Maggiorella L, Eschwege P, Bourhis J, Soria JC, Abdulkarim B. Environmental, genetic, and molecular features of prostate cancer. Lancet Oncol 2004;5:303-13.
3. Peters ME, Ostrander EA. Prostate cancer: simplicity to complexity. Nat Genet 2001;27:134-5.
4. Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-4.
5. Berthon P, Valeri A, Cohen-Akenine A, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998;62:1416-24.
6. Gibbs M, Stanford JL, McIndoe RA, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999;64:776-87.
7. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20:175-9.
8. Berry R, Schroeder JJ, French AJ, et al. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000;67:82-91.
9. Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-80.
10. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002;32:321-5.
11. Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
12. Giovannucci E, Stampfer MJ, Krithivas K, et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 1997;94:3320-3.
13. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166-70.
14. Makridakis NM, Ross RK, Pike MC, et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet 1999;354:975-8.
15. Shirai T, Takahashi S, Cui L, et al. Experimental prostate carcinogenesis: rodent models. Mutat Res 2000;462:219-26.
16. Shain SA, McCullough B, Segaloff A. Spontaneous adenocarcinomas of the ventral prostate of aged AXC rats. J Natl Cancer Inst 1975;55:177-80.
17. Ward JM, Reznik G, Stinson SF, Lattuada CP, Longfellow DG, Cameron TP. Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. Lab Invest 1980;43:517-22.
18. Isaacs JT. The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res 1984;44:5785-96.
19. Bosland MC, Dreef-Van Der Meulen HC, Sukumar S, et al. Multistage prostate carcinogenesis: the role of hormones. Princess Takamatsu Symp 1991;22:109-23.
20. Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 1994;25:249-65.
21. Kondo Y, Homma Y, Aso Y, Kakizoe T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 1994;54:6129-32.
22. Homma Y, Kaneko M, Kondo Y, Kawabe K, Kakizoe T. Inhibition of rat prostate carcinogenesis by a 5α-reductase inhibitor, FK143. J Natl Cancer Inst 1997;89:803-7.
23. Homma Y, Kondo Y, Kaneko M, et al. Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogenesis 2004;25:1011-4.
24. Reznik G, Hamlin MH II, Ward JM, Stinson SF. Prostatic hyperplasia and neoplasia in aging F344 rats. Prostate 1981;2:261-8.
25. Weisburger JH, Rivenson A, Reinhardt J, Braley J, Pittman B, Zang E. On the occurrence of Leydig cell tumors in the F344 rat. Cancer Lett 2002;182:213-6.
26. Heywood LH. Testosterone levels in the male laboratory rat: variation under experimental conditions. Int J Androl 1980;3:519-29.
27. Ushijima T, Yamamoto M, Suzui M, et al. Chromosomal mapping of genes controlling development, histological grade, depth of invasion, and size of rat stomach carcinomas. Cancer Res 2000;60:1092-6.
28. Yoshida Y, Ushijima T, Yamashita S, Imai K, Sugimura T, Nagao M. Development of the arbitrarily primed-representational difference analysis method and chromosomal mapping of isolated high throughput rat genetic markers. Proc Natl Acad Sci U S A 1999;96:610-5.
29. Yamashita S, Yoshida Y, Kurahashi A, Sugimura T, Ushijima T. Construction of a high-throughput rat genetic mapping system with 466 arbitrarily primed-representational difference analysis markers. Mamm Genome 2000;11:982-8.
30. Yamashita S, Furumoto K, Nobukiyo A, Kamohara M, Ushijima T, Furukawa T. Mapping of A gene responsible for cataract formation and its modifier in the UPL rat. Invest Ophthalmol Vis Sci 2002;43:3153-9.
31. Lander ES, Green P, Abrahamson J, et al. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1987;1:174-81.
32. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7.
33. Kuramoto T, Morimura K, Yamashita S, et al. Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res 2002;62:3592-7.
34. Abe M, Yamashita S, Kuramoto T, et al. Global expression analysis of N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach carcinomas using oligonucleotide microarrays. Carcinogenesis 2003;24:861-7.
35. Yamashita S, Nomoto T, Ohta T, Ohki M, Sugimura T, Ushijima T. Differential expression of genes related to levels of mucosal cell proliferation among multiple rat strains by using oligonucleotide microarrays. Mamm Genome 2003;14:845-52.
36. Habib FK, Ross M, Bayne CW, Bollina P, Grigor K, Chapman K. The loss of 5α-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis. Clin Cancer Res 2003;9:1815-9.
37. Konishi H, Okajima H, Okada Y, Yamamoto H, Fukai K, Watanabe H. High levels of cholesteryl esters, progesterone and estradiol in the testis of aging male Fischer 344 rats: feminizing Leydig cell tumors. Chem Pharm Bull (Tokyo) 1991;39:501-4.
38. Wayne ML, McIntyre LM. Combining mapping and arraying: an approach to candidate gene identification. Proc Natl Acad Sci U S A 2002;99:14903-6.
39. Papandreou CN, Usmani B, Geng Y, et al. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 1998;4:50-7.
40. Wiklund F, Gillanders EM, Albertus JA, et al. Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003;57:290-7.
41. Suzuki H, Komiya A, Emi M, et al. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 1996;17:225-33.
42. Osman I, Scher H, Dalbagni G, Reuter V, Zhang ZF, Cordon-Cardo C. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Int J Cancer 1997;71:580-4.
43. Gao AC, Lou W, Ichikawa T, Denmeade SR, Barrett JC, Isaacs JT. Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2. Prostate 1999;38:46-54.
44. van Dekken H, Paris PL, Albertson DG, et al. Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer 2004;39:249-56.